Quadrant Capital Group’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,277
| Closed | -$240K | – | 1387 |
|
|
2025
Q1 | $240K | Buy |
8,277
+7,537
| +1,019% | +$218K | 0.01% | 1211 |
|
|
2024
Q4 | $27.5K | Hold |
740
| – | – | ﹤0.01% | 1740 |
|
|
2024
Q3 | $35.9K | Sell |
740
-53
| -7% | -$2.57K | ﹤0.01% | 1625 |
|
|
2024
Q2 | $31.7K | Sell |
793
-10
| -1% | -$400 | ﹤0.01% | 1647 |
|
|
2024
Q1 | $35.3K | Sell |
803
-223
| -22% | -$9.79K | ﹤0.01% | 1580 |
|
|
2023
Q4 | $63.5K | Buy |
1,026
+223
| +28% | +$13.8K | 0.01% | 1255 |
|
|
2023
Q3 | $36.9K | Sell |
803
-19
| -2% | -$874 | ﹤0.01% | 1412 |
|
|
2023
Q2 | $47.2K | Buy |
822
+10
| +1% | +$575 | ﹤0.01% | 1287 |
|
|
2023
Q1 | $30.5K | Buy |
812
+511
| +170% | +$19.2K | ﹤0.01% | 1484 |
|
|
2022
Q4 | $8.43K | Sell |
301
-103
| -25% | -$2.89K | ﹤0.01% | 2036 |
|
|
2022
Q3 | $11K | Buy |
404
+177
| +78% | +$4.82K | ﹤0.01% | 1826 |
|
|
2022
Q2 | $8K | Sell |
227
-167
| -42% | -$5.89K | ﹤0.01% | 1758 |
|
|
2022
Q1 | $14K | Buy |
394
+149
| +61% | +$5.29K | ﹤0.01% | 1482 |
|
|
2021
Q4 | $6K | Sell |
245
-111
| -31% | -$2.72K | ﹤0.01% | 1791 |
|
|
2021
Q3 | $7K | Buy |
356
+248
| +230% | +$4.88K | ﹤0.01% | 1733 |
|
|
2021
Q2 | $2K | Sell |
108
-10
| -8% | -$185 | ﹤0.01% | 2067 |
|
|
2021
Q1 | $2K | Buy |
118
+63
| +115% | +$1.07K | ﹤0.01% | 2020 |
|
|
2020
Q4 | $1K | Hold |
55
| – | – | ﹤0.01% | 2044 |
|
|
2020
Q3 | $1K | Hold |
55
| – | – | ﹤0.01% | 1908 |
|
|
2020
Q2 | $1K | Hold |
55
| – | – | ﹤0.01% | 2003 |
|
|
2020
Q1 | $1K | Buy |
+55
| New | +$1K | ﹤0.01% | 1947 |
|
|
2019
Q3 | – | Sell |
-2,636
| Closed | -$54K | – | 2286 |
|
|
2019
Q2 | $54K | Hold |
2,636
| – | – | 0.01% | 1181 |
|
|
2019
Q1 | $53K | Buy |
+2,636
| New | +$53K | 0.01% | 1182 |
|